CpG Island Methylation in Colorectal Cancer: Past, Present and Future

The concept of a CpG island methylator phenotype, or CIMP, quickly became the focus of several colorectal cancer studies describing its clinical and pathological features after its introduction in 1999 by Toyota and colleagues. Further characterization of CIMP in tumors lead to widespread acceptance...

Descripción completa

Detalles Bibliográficos
Autores principales: Curtin, Karen, Slattery, Martha L., Samowitz, Wade S.
Formato: Texto
Lenguaje:English
Publicado: SAGE-Hindawi Access to Research 2011
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3090226/
https://www.ncbi.nlm.nih.gov/pubmed/21559209
http://dx.doi.org/10.4061/2011/902674

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3090226/
https://www.ncbi.nlm.nih.gov/pubmed/21559209
http://dx.doi.org/10.4061/2011/902674

Ejemplares similares